Literature DB >> 16311418

Pituitary carcinoma: diagnosis and treatment.

M Beatriz S Lopes1, Bernd W Scheithauer, David Schiff.   

Abstract

Pituitary carcinomas are rare pituitary tumors that by definition have cerebrospinal and/or systemic metastases. Most of the tumors occur in the setting of multiple recurrences of invasive pituitary adenomas. This article reviews the clinical presentation of these tumors, their neuroimaging and pathological features, tumor pathogenesis, and possible treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311418     DOI: 10.1385/ENDO:28:1:115

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  47 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Case of the season: metastatic pituitary carcinoma mimicking meningioma.

Authors:  Jose M Negron-Soto; Michaux Kilpatrick; Neville Irani; Mauricio Castillo
Journal:  Semin Roentgenol       Date:  2004-10       Impact factor: 0.800

Review 3.  Radiation therapy in the multimodal treatment approach of pituitary adenoma.

Authors:  Gerd Becker; Martin Kocher; Rolf-Dieter Kortmann; Frank Paulsen; Branislav Jeremic; Rolf-Peter Müller; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2002-04       Impact factor: 3.621

4.  Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinoma.

Authors:  A Zahedi; G L Booth; H S Smyth; W E Farrell; R N Clayton; S L Asa; S Ezzat
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

Review 5.  Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.

Authors:  R B Mountcastle; B S Roof; R K Mayfield; D B Mordes; J Sagel; P J Biggs; S E Rawe
Journal:  Am J Med Sci       Date:  1989-08       Impact factor: 2.378

Review 6.  Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors.

Authors:  E Bombardieri; E Seregni; C Villano; A Chiti; E Bajetta
Journal:  Q J Nucl Med Mol Imaging       Date:  2004-06       Impact factor: 2.346

Review 7.  Pituitary carcinoma: a review of the literature.

Authors:  Brian T Ragel; William T Couldwell
Journal:  Neurosurg Focus       Date:  2004-04-15       Impact factor: 4.047

Review 8.  Intradural metastatic spinal cord compression from ACTH-secreting pituitary carcinoma.

Authors:  J Tysome; K K Gnanalingham; I Chopra; N Mendoza
Journal:  Acta Neurochir (Wien)       Date:  2004-09-09       Impact factor: 2.216

Review 9.  Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan.

Authors:  Y Greenman; P Woolf; J Coniglio; R O'Mara; L Pei; J W Said; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

10.  A pituitary parasellar tumor with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides.

Authors:  F E Kaiser; D N Orth; K Mukai; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1983-09       Impact factor: 5.958

View more
  21 in total

Review 1.  Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.

Authors:  A K Annamalai; A F Dean; N Kandasamy; K Kovacs; H Burton; D J Halsall; A S Shaw; N M Antoun; H K Cheow; R W Kirollos; J D Pickard; H L Simpson; S J Jefferies; N G Burnet; M Gurnell
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 2.  Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.

Authors:  Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

Review 3.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

Review 4.  Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.

Authors:  Frederick Yoo; Edward C Kuan; Anthony P Heaney; Marvin Bergsneider; Marilene B Wang
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 5.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

6.  Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation.

Authors:  Jillian Maclean; Matthew Aldridge; Jamshed Bomanji; Susan Short; Naomi Fersht
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 7.  Management of aggressive pituitary adenomas and pituitary carcinomas.

Authors:  Anthony Heaney
Journal:  J Neurooncol       Date:  2014-03-02       Impact factor: 4.130

8.  Invasive adenoma and pituitary carcinoma: a SEER database analysis.

Authors:  Tara M Hansen; Sachin Batra; Michael Lim; Gary L Gallia; Peter C Burger; Roberto Salvatori; Gary Wand; Alfredo Quinones-Hinojosa; Lawrence Kleinberg; Kristin J Redmond
Journal:  Neurosurg Rev       Date:  2014-02-14       Impact factor: 3.042

9.  Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy.

Authors:  Laura E Donovan; Ashley V Arnal; Shih-Hsiu Wang; Yazmin Odia
Journal:  CNS Oncol       Date:  2016-09-12

Review 10.  Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

Authors:  Agatha A van der Klaauw; Tina Kienitz; Christian J Strasburger; Johannes W A Smit; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.